Cargando…
The Antitumor Effect and Hepatotoxicity of a Hexokinase II Inhibitor 3-Bromopyruvate: In Vivo Investigation of Intraarterial Administration in a Rabbit VX2 Hepatoma Model
OBJECTIVE: The purpose of this study was to compare the antitumor effect and hepatotoxicity of an intraarterial delivery of low-dose and high-dose 3-bromopyruvate (3-BrPA) and those of a conventional Lipiodol-doxorubicin emulsion in a rabbit VX2 hepatoma model. MATERIALS AND METHODS: This experiment...
Autores principales: | Jae, Hwan Jun, Chung, Jin Wook, Park, Hee Sun, Lee, Min Jong, Lee, Ki Chang, Kim, Hyo-Cheol, Yoon, Jung Hwan, Chung, Hesson, Park, Jae Hyung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770822/ https://www.ncbi.nlm.nih.gov/pubmed/19885316 http://dx.doi.org/10.3348/kjr.2009.10.6.596 |
Ejemplares similares
-
FDG-PET for Evaluating the Antitumor Effect of Intraarterial 3-Bromopyruvate Administration in a Rabbit VX2 Liver Tumor Model
por: Park, Hee Sun, et al.
Publicado: (2007) -
Effects of Arsenic Trioxide on Radiofrequency Ablation of VX2 Liver Tumor: Intraarterial versus Intravenous Administration
por: Seong, Nak Jong, et al.
Publicado: (2012) -
Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors
por: Lee, Jae Hwan, et al.
Publicado: (2019) -
Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis
por: Gandham, Srujan Kumar, et al.
Publicado: (2015) -
The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression
por: Ho, Nelson, et al.
Publicado: (2016)